As reported in the Journal of Clinical Oncology by Gary H. Lyman, MD, of Fred Hutchinson Cancer Research Center, and colleagues, an ASCO clinical practice guideline update panel made no changes to the 2014 recommendations for sentinel lymph node biopsy in women with early-stage breast cancer.
The update panel searched the literature for randomized controlled trials, systematic reviews, meta-analyses, and clinical practice guidelines reported between 2012 through July 2016. Eight publications were identified and reviewed; the findings reaffirmed the 2014 recommendations, with none of the information prompting changes to the guideline. The update panel was co-chaired by Dr. Lyman and Armando E. Giuliano, MD, of Cedars-Sinai Medical Center, Los Angeles.
Recommendations
The current recommendations are briefly summarized here. The first three are supported by evidence from randomized controlled trials.
Mark R. Somerfield, PhD, of ASCO, is the corresponding author of the Journal of Clinical Oncology article.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.